These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11555407)

  • 1. Shoulder-pad sign of amyloidosis: structure of an Ig kappa III protein.
    Liepnieks JJ; Burt C; Benson MD
    Scand J Immunol; 2001 Oct; 54(4):404-8. PubMed ID: 11555407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation.
    Schormann N; Murrell JR; Liepnieks JJ; Benson MD
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9490-4. PubMed ID: 7568160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.
    Engvig JP; Olsen KE; Gislefoss RE; Sletten K; Wahlström O; Westermark P
    Scand J Immunol; 1998 Jul; 48(1):92-8. PubMed ID: 9714416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain-associated amyloid deposits comprised of a novel kappa constant domain.
    Solomon A; Weiss DT; Murphy CL; Hrncic R; Wall JS; Schell M
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9547-51. PubMed ID: 9689117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALkappa(I) (UNK) - primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review.
    Wiegel NM; Mentele R; Kellermann J; Meyer L; Riess H; Linke RP
    Amyloid; 2010 Mar; 17(1):10-23. PubMed ID: 20146644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
    Lim A; Wally J; Walsh MT; Skinner M; Costello CE
    Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Apr; 245(3):713-6. PubMed ID: 9588180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
    Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
    Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin kappa light chain deposits. A human disease to study alterations of protein conformation.
    Kaplan B; Vidal R; Kumar A; Ghiso J; Frangione B; Gallo G
    Clin Exp Immunol; 1997 Dec; 110(3):472-8. PubMed ID: 9409653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.
    Hoshii Y; Nanbara H; Cui D; Takahashi M; Ikeda E
    Med Mol Morphol; 2012 Jun; 45(3):124-8. PubMed ID: 23001294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).
    Odani S; Komori Y; Gejyo F
    Amyloid; 1999 Jun; 6(2):77-88. PubMed ID: 10439113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain.
    Wally J; Kica G; Zhang Y; Ericsson T; Connors LH; Benson MD; Liepnieks JJ; Murray J; Skinner M; Comenzo RL
    Biochim Biophys Acta; 1999 May; 1454(1):49-56. PubMed ID: 10354514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
    Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
    Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
    Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
    Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid sequence of a kappa I primary (AL) amyloid protein (AND).
    Liepnieks JJ; Dwulet FE; Benson MD
    Mol Immunol; 1990 Jun; 27(6):481-5. PubMed ID: 2116593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized amyloidosis of the larynx: evidence for light chain composition.
    Berg AM; Troxler RF; Grillone G; Kasznica J; Kane K; Cohen AS; Skinner M
    Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):884-9. PubMed ID: 8239352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global fluctuations of the immunoglobulin domains under physiological conditions.
    Kawata Y; Hamaguchi K
    Biopolymers; 1990; 30(3-4):389-94. PubMed ID: 2126211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionation of primary amyloid fibrils. Characterization and chemical interaction of the subunits.
    Lian JB; Skinner M; Benson MD; Cohen AS
    Biochim Biophys Acta; 1977 Mar; 491(1):167-76. PubMed ID: 402949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary amyloidosis associated with a novel heavy-chain fragment (AH amyloidosis).
    Solomon A; Weiss DT; Murphy C
    Am J Hematol; 1994 Feb; 45(2):171-6. PubMed ID: 8141123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.